Objective
One person in 3000 in the world suffers from Retinis Pigmentosa, which leads to degeneration of essential cells of retina: the polarized photosensitive cells or photoreceptors. Several forms of Retinis Pigmentosa can cause partial or total blindness.
Their origin is still unknown and there is no efficient therapy to cure or even prevent them. Numerous studies have shown that CRB1, one of the 3 genes encoding for the human family of proteins CRUMBS (Crb1, 2 and 3), is mutated in 60% of patients suffering from a severe form of autosomal recessive Retinis Pigmentosa called RP12. Other reports implicate Crb3 in vesicular transport at the apical membrane of epithelial polarized cells and at the tight junctions between those cells. The function and regulation of the Crumbs family of proteins are unknown.
However, it has been shown that Crb2 and Crb3 are necessary for the formation of the primary cilium at the apical membrane of epithelial cells. The physiological role of the primary cilium remains elusive. Interestingly, several proteins that are localized to the primary cilium are responsible, when mutated, for diseases like the Bardet-Biedl syndrome, polycystic kidney disease or Retinis Pigmentosa. The aim of this project is to study the cellular and molecular role of the Crumbs protein family in morphogenesis and physiology of the retina.
We want to understand the mechanisms by which the Crumbs proteins are necessary for cell polarity establishment by the formation and the maintenance of the apical membrane, the tight junctions, as well as the primary cilium. More precisely, we will seek for the role of Crb3 and its partners in the apical membrane morphogenesis and physiology, in epithelial cells in general, and in photoreceptors in particular.
The results of this research should allow the opening of new avenues for molecular and genetic studies on human retina degeneration and lead to new strategies for therapy against Retinis Pigmentosa and other degeneration diseases.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences biochemistry biomolecules proteins
- medical and health sciences clinical medicine ophthalmology
- natural sciences biological sciences cell biology cell polarity
- medical and health sciences basic medicine physiology
- medical and health sciences clinical medicine nephrology kidney diseases
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP6-2004-MOBILITY-12
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.